Analysts expect Vir Biotechnology, Inc. to report revenue of 6.15 M for Q4 26, against a range of 5.61 M to 6.69 M. The most recent reported quarter, Q3 26, came in at 188,000.00, a 79.7% miss against the 926,751.70 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 2.38 M | 12.37 M | 3.03 M | 1.21 M | 240,000.00 | 64.07 M | -29,000.00 | 238.95 M | 188,000.00 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | 5.89 M | 8.33 M | 8.73 M | 2.77 M | 2.25 M | 22.96 M | 62.54 M | 144.06 M | 1.01 M | 6.69 M | 25.86 M | 8.93 M | -54.99 M | -25.74 M | 42.45 M | 84.57 M | -23.23 M | |||||||||
| Low Estimate | 4.93 M | 7.60 M | 7.79 M | 2.41 M | 1.90 M | 19.06 M | 55.57 M | 121.61 M | 838,916.03 | 5.61 M | 21.69 M | 8.32 M | -60.64 M | -31.20 M | 39.90 M | 78.76 M | -26.60 M | |||||||||
| Consensus Estimate | 5.41 M | 7.96 M | 8.26 M | 2.59 M | 2.08 M | 21.01 M | 59.06 M | 132.84 M | 926,751.70 | 6.15 M | 23.78 M | 8.63 M | -57.81 M | -28.47 M | 41.17 M | 81.67 M | -24.91 M |
Analysts expect Vir Biotechnology, Inc. to report earnings per share of -0.69 for Q4 26, against a range of -0.73 to -0.65. The most recent reported quarter, Q3 26, came in at -0.57, a 28.0% beat against the -0.79 consensus.
| Metric | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | Q3 26 | Q4 26 | Q1 27 | Q2 27 | Q3 27 | Q4 27 | Q1 28 | Q2 28 | Q3 28 | Q4 28 | Q1 29 | Q2 29 | Q3 29 | Q4 29 | Q1 30 | Q2 30 | Q3 30 | Q4 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -1.56 | -0.76 | -0.88 | -0.80 | -1.17 | -0.31 | -0.85 | 0.47 | -0.57 | - | - | - | - | - | - | - | - | |||||||||
| High Estimate | -0.93 | -0.79 | -0.76 | -0.69 | -0.80 | -0.49 | -0.10 | 0.37 | -0.72 | -0.65 | -0.55 | -0.63 | -0.91 | -0.61 | -0.44 | -0.29 | -0.84 | |||||||||
| Low Estimate | -1.11 | -0.91 | -0.82 | -0.81 | -0.96 | -0.53 | -0.10 | 0.33 | -0.86 | -0.73 | -0.59 | -0.75 | -0.99 | -0.69 | -0.50 | -0.33 | -0.98 | |||||||||
| Consensus Estimate | -1.02 | -0.85 | -0.79 | -0.75 | -0.88 | -0.51 | -0.10 | 0.35 | -0.79 | -0.69 | -0.57 | -0.69 | -0.95 | -0.65 | -0.47 | -0.31 | -0.91 |
Pull Wall Street consensus for Vir Biotechnology, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=VIR&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "VIR", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=VIR&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();